COVID-19 vaccine developed by Oxford University develops promising immune response in human trial
- 4 years ago
영국 옥스퍼드대 코로나19 백신 "모든 투약자 면역 반응 생성"
We begin with some potentially positive news.
As the world awaits an effective vaccine against COVID-19,... some promising signs are emerging.
Scientists at Oxford University in the U.K. say their experimental vaccine prompted a protective immune response in hundreds of people who got the shot.
Kim Hyo-sun starts us off.
A potential COVID-19 vaccine developed by Oxford University has reportedly produced a promising immune response in a large, early-stage human trial.
According to newly released data published Monday in the medical journal, The Lancet,... 100 percent of the participants in the trial developed neutralizing antibodies.
The trial was carried out in April on some 1-thousand people between the ages of 18 and 55 in the UK.
Researchers explained that the vaccine, being jointly developed with pharmaceutical giant AstraZeneca, also produced killer T-cells that help patients combat the infection by attacking the infected cells.
The World Health Organization welcomed the news,... but warned that there's a long road ahead
We do welcome the study and congratulate our colleagues at the Oxford University's General Institute and the Oxford Vaccine Group. And and obviously our colleagues at AstraZeneca for getting this data out there... But again, there is a long way to go. These are phase one studies. We now need to move into larger scale, real world trials."
There was also positive news on vaccine development in other parts of the world,... with America's Pfizer and Germany's BioNTech successfully immunizing their participants.
The trial carried out on 60 adults in Germany proved to be safe and successfully induced an immune response.
Such a response echoed results of a similar test conducted in the U.S.
Pfizer and BioNTech now plan to begin testing on some 30-thousand volunteers this month to prove the efficacy of their vaccine.
Kim Hyo-sun, Arirang News.
We begin with some potentially positive news.
As the world awaits an effective vaccine against COVID-19,... some promising signs are emerging.
Scientists at Oxford University in the U.K. say their experimental vaccine prompted a protective immune response in hundreds of people who got the shot.
Kim Hyo-sun starts us off.
A potential COVID-19 vaccine developed by Oxford University has reportedly produced a promising immune response in a large, early-stage human trial.
According to newly released data published Monday in the medical journal, The Lancet,... 100 percent of the participants in the trial developed neutralizing antibodies.
The trial was carried out in April on some 1-thousand people between the ages of 18 and 55 in the UK.
Researchers explained that the vaccine, being jointly developed with pharmaceutical giant AstraZeneca, also produced killer T-cells that help patients combat the infection by attacking the infected cells.
The World Health Organization welcomed the news,... but warned that there's a long road ahead
We do welcome the study and congratulate our colleagues at the Oxford University's General Institute and the Oxford Vaccine Group. And and obviously our colleagues at AstraZeneca for getting this data out there... But again, there is a long way to go. These are phase one studies. We now need to move into larger scale, real world trials."
There was also positive news on vaccine development in other parts of the world,... with America's Pfizer and Germany's BioNTech successfully immunizing their participants.
The trial carried out on 60 adults in Germany proved to be safe and successfully induced an immune response.
Such a response echoed results of a similar test conducted in the U.S.
Pfizer and BioNTech now plan to begin testing on some 30-thousand volunteers this month to prove the efficacy of their vaccine.
Kim Hyo-sun, Arirang News.